Timing of response and long term efficacy of Omalizumab in non-clonal Mast Cell Activation Syndrome: A case series.

Caminati, Marco; Olivieri, Elisa; Nalin, Francesca; Zanotti, Roberta; Senna, Gianenrico; Schiappoli, Michele; Dama, Annarita; Bonadonna, Patrizia

Caminati, Marco; Olivieri, Elisa; Nalin, Francesca; Zanotti, Roberta; Senna, Gianenrico; Schiappoli, Michele; Dama, Annarita; Bonadonna, Patrizia.

Afiliación

Caminati M; Department of Medicine, University of Verona, Verona, Italy; Asthma Center and Allergy Unit, Verona University Hospital, Verona, Italy. Electronic address: ma.caminati@gmail.com.
Olivieri E; Asthma Center and Allergy Unit, Verona University Hospital, Verona, Italy.
Nalin F; Department of Medicine, Specialization Course in Allergy and Clinical Immunology, University of Verona, Verona, Italy.
Zanotti R; Department of Medicine, Haematology Unit, Verona University Hospital, Verona, Italy.
Senna G; Asthma Center and Allergy Unit, Verona University Hospital, Verona, Italy.
Schiappoli M; Asthma Center and Allergy Unit, Verona University Hospital, Verona, Italy.
Dama A; Asthma Center and Allergy Unit, Verona University Hospital, Verona, Italy.
Bonadonna P; Asthma Center and Allergy Unit, Verona University Hospital, Verona, Italy.

Eur J Intern Med ; 71: 104-106, 2020 01.

Article en En | MEDLINE | ID: mdl-31735545

Asunto(s)

Mastocitosis; Omalizumab; Humanos; Mastocitos; Omalizumab/uso terapéutico

Palabras clave

Mastocytosis; Non-clonal mast cell activation syndrome; Omalizumab

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mastocitosis / Omalizumab Límite: Humans Idioma: En Revista: Eur J Intern Med Asunto de la revista: MEDICINA INTERNA Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google